We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
72 hedge funds and large institutions have $57.8M invested in Jade Biosciences in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
356% more call options, than puts
Call options by funds: $301K | Put options by funds: $66K
28% more capital invested
Capital invested by funds: $45.1M → $57.8M (+$12.7M)
28% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 18
0.04% more ownership
Funds ownership: 2.69% → 2.74% (+0.04%)
10% less funds holding
Funds holding: 80 → 72 (-8)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
23
Reduced
18
Closed
19
Calls
$301K
Puts
$66K
Net Calls
+$235K
Net Calls Change
-$6K
Top Buyers
| 1 |
EP
Eversept Partners
New York
|
+$894K |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$737K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$662K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$529K |
| 5 |
Morgan Stanley
New York
|
+$520K |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$1.34M |
| 2 |
Millennium Management
New York
|
-$821K |
| 3 |
SG Americas Securities
New York
|
-$310K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$275K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$247K |
